From Basic Research to Clinical Practice: Considerations for Treatment Drugs for Silicosis.

Li, Rou; Kang, Huimin; Chen, Shi

Li, Rou; Kang, Huimin; Chen, Shi.

Affiliation

Li R; Key Laboratory of Molecular Epidemiology of Hunan Province, Hunan Normal University, Changsha 410013, China.
Kang H; Key Laboratory of Molecular Epidemiology of Hunan Province, Hunan Normal University, Changsha 410013, China.
Chen S; Key Laboratory of Molecular Epidemiology of Hunan Province, Hunan Normal University, Changsha 410013, China.

Int J Mol Sci ; 24(9)2023 May 05.

Article in En | MEDLINE | ID: mdl-37176040

Subject(s)

Idiopathic Pulmonary Fibrosis; Lung Diseases; Silicosis; Humans; Silicosis/drug therapy; Silicosis/pathology; Idiopathic Pulmonary Fibrosis/drug therapy; Idiopathic Pulmonary Fibrosis/etiology; Idiopathic Pulmonary Fibrosis/pathology; Fibrosis; Silicon Dioxide/therapeutic use

Key words

IPF; pulmonary fibrosis; silicosis; treatment drugs

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Silicosis / Idiopathic Pulmonary Fibrosis / Lung Diseases Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Document type: Article Affiliation country: China Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google